Why Cardiogenic Shock Is a Hospital-Wide Concern, Not Just a Cardiology Issue

Blog

The Society for Cardiovascular Angiography and Interventions (SCAI) emphasizes that CS management requires an integrated approach. Successful CS management must transcend departmental silos, advocating for standardized protocols across all hospital settings to ensure rapid identification and intervention regardless of where a
patient initially presents. The SCAI updated its widely used staging system in 2022 to categorize CS severity based on hemodynamic status, hypoperfusion markers, and the use of advanced circulatory support, ranging from A (at risk) to E (extremis). Higher SCAI stages consistently correlate with higher short-term mortality.

Timely clinical recognition of CS is consistently linked with improved patient outcomes. To achieve this, effective management requires early recognition by all care providers, not only cardiologists. Hospitals can implement effective CS management by taking critical steps, including:

  • Building a multidisciplinary shock team: This dedicated team should comprise various specialists, including nurses, cardiologists, intensivists, emergency department (ED) staff, surgeons, and heart failure specialists, to facilitate early diagnosis, repeated assessment, and rapid decision-making.
  • Adopting standardized protocols hospital-wide: This involves standardizing institutional CS care and training staff across all departments to ensure consistent management and escalation processes.
Conclusion

Cardiogenic shock is one of the most fatal complications in cardiac care, far exceeding the confines of the ICU. Early recognition and timely intervention through hospital-wide strategies show strong evidence for improving patient outcomes, reducing the strain on clinical teams, and potentially achieving substantial healthcare savings. By adopting a unified, data-driven approach across the entire hospital, healthcare systems can move beyond fragmented care to a truly integrated strategy, transforming how CS is identified and managed, ultimately saving lives.


Contact Us

This field is for validation purposes and should be left unchanged.
Name(Required)
This site is protected by reCAPTCHA and the Google Privacy Policy andTerms of Service apply.

References

Sinha, S, Morrow, D, Kapur, N. et al. 2025 Concise Clinical Guidance: An ACC Expert Consensus Statement on the Evaluation and Management of Cardiogenic Shock: A Report of the American College of Cardiology Solution Set Oversight Committee. JACC. 2025 Apr, 85 (16) 1618–1641. https://doi.org/10.1016/j.jacc.2025.02.018

Early Prediction of Cardiogenic Shock Using Machine Learning https://pubmed.ncbi.nlm.nih.gov/35911549/

The Lancet: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2824%2901818-X/fulltext

References to earlier recognition are based on published research and do not imply predictive or diagnostic functions of the Etiometry Platform.


Related

First Automated Hospital-Specific Cardiogenic Shock Classification Tool for Critical Care Teams

Etiometry has received FDA clearance (K254066) for the Etiometry Cardiogenic Shock Tool: the first-ever automated solution for hospital-specific cardiogenic shock classification and tracking (aligned with each institution’s own protocols) using physiologic monitoring data. This is Etiometry’s 11th FDA clearance overall, and the only solution that automates SCAI staging directly from physiologic monitoring data. For cardiac […]

Etiometry Receives a First-Ever FDA Clearance for Automating Hospital-Specific Cardiogenic Shock Classification and Tracking

BOSTON, Mass. – April 8, 2026 – Etiometry, a leader in AI-driven clinical intelligence, today announced it has received FDA clearance (K254066) for the first-ever solution for automation of hospital-specific cardiogenic shock classification and tracking by directly utilizing data from physiologic monitoring, the Etiometry Cardiogenic Shock Tool.  Cardiogenic shock remains a critical challenge, with delayed identification […]

Boston Children’s enhances care with clinical intelligence platform

At Boston Children’s Hospital, Dr. Peter Laussen and Dr. Joshua Salvin are leading the way as true pioneers in clinical intelligence and AI. Through ongoing collaboration, their work has evolved to better integrate and interpret complex patient data, helping care teams shift toward more informed, data-driven decision-making in real time. Read how they helped shape […]